-
Mashup Score: 0
Dupilumab improves severe CRSwNP symptoms, such as nasal obstruction and quality of life, showing significant efficacy within 6-12 months.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet
Dupilumab improves severe CRSwNP symptoms, such as nasal obstruction and quality of life, showing significant efficacy within 6-12 months.
A new study demonstrates #dupilumab's sustained efficacy for severe uncontrolled #CRSwNP, finding significant symptom relief and improved quality of life within 6–12 months. 🔗 Read more: https://t.co/zhyqyURhMp